For commercial accounts, this cell line is only distributed under the terms of a fully signed and executed ATCC® Material Transfer Agreement and Addendum. If the commercial account is screening per completed Addendum, the recipient will be required to pay a Screening Fee (ATCC® ACS-2103™) of $4000.00.
Screening Use is defined as use of Biological Material in small molecule and biologic drug discovery, including initial target identification and validation, assay development, high throughput screening, hit identification, lead optimization, and selection of candidates for clinical development.
If the commercial account is not screening per the completed Addendum, the recipient will not be required to pay a Screening Fee.
In addition to the foregoing, this product's use is governed by the Limited Use License. For information on purchasing a license to use this product for research (for-profit entities) or commercial purposes (any entity) other than those permitted in the limited use label license, contact the Licensing Department, Life Technologies Corporation, 5791 Van Allen Way, Carlsbad, California 92008. Phone (760) 603-7200 or firstname.lastname@example.org
In addition to the foregoing, any proposed commercial use of ATCC® CRL-4045™ [TIME-GFP] must also be negotiated with University of California, San Francisco, Office of Technology Management, 3333 California Street, Suite S-11, San Francisco, CA 94143-1209, Tel: 415.502.1585, Fax: 415.502.1661.